>> LIVE FROM LONDON. THIS IS BLOOMBERG DAYBREAK. I’M OLIVER CROOK.THE FED MINUTES SHOW SOME OFFICIALS CONSIDERING HIKES. STOCKS RALLY IN ASIA WITH TECH SHARES EASING GAINS AS AI FEARS EASE. CONFLICT CONCERNS.OIL STEADIES AFTER THE BIGGEST RALLY SINCE OCTOBER FOLLOWING A REPORT THAT U.S. MILITARY INTERVENTION IRON COULD COME SOONER THAN EXPECTED. EUROPEAN EARNINGS IN FOCUS. NESTLE HITTING THE WIRE NOW.AIRBUS SAYING THE LACK OF RELIABLE ENGINE SUPPLY IS HURTING ITS DELIVERY GOALS. LOOKING AT THE MARKETS THIS ...

Core Insights - The food giant is planning to divest its ice-cream business and focus on consolidating its operations around four main categories [1] Group 1 - The company aims to streamline its portfolio by offloading non-core segments, specifically the ice-cream business [1] - The consolidation strategy will enhance operational efficiency and allow for better resource allocation across the four main categories [1]

雀巢集团（以下简称"集团"）于2026年2月19日发布2025年业绩。报告显示，集团2025 年有机增长率 （OG）达 3.5%，基础交易营业利润率（UTOP）为16.1%的，净利润为90亿瑞士法郎，并创造了92亿瑞 士法郎的自由现金流。 集团针对性的增长投资有效推动实际内部增长率从2025年上半年的0.2% 加速提升至下半年的1.4%，各 品类及大区均实现改善。集团销量市场份额目前已企稳，且增长势头延续至2025年第四季度，该季度有 机增长率为4.0%。"十亿俱乐部"品牌市场份额增长由负转正，创下十多年来的最佳表现。大中华区受渠 道库存调整的影响减弱，第四季度有机增长率较前两个季度有所改善。 第二，以实际内部增长率拉动的业务增长为核心。集团将高潜力增长平台的业务规模扩大至占集团销售 额的30%，实现高个位数增长，并将在2026年获得6亿瑞士法郎额外投资支持；升级并进一步强化消费 者洞察、创新及营销能力之间的衔接。 第三，加速业务转型。集团简化组织架构，并强化本地责任制，提升决策效率与响应速度；同时加速推 进成本优化举措，白领岗位运营效率提升方面已提前达成目标，实现了10亿瑞士法郎年度节约目标中的 20%。 ...

Core Viewpoint - Nestle is negotiating to divest its remaining ice cream businesses as part of CEO Philipp Navratil's strategy to streamline the company [1] Group 1 - The decision to sell the ice cream segment aligns with the company's broader efforts to focus on core areas of its business [1] - This move is part of a larger trend in the consumer food industry where companies are reassessing their product portfolios to enhance operational efficiency [1] - The divestiture reflects Nestle's commitment to optimizing its operations and potentially reallocating resources to more profitable segments [1]

Market Overview - European stocks are expected to open in mixed territory with the U.K.'s FTSE index projected to rise by 0.15%, while Germany's DAX is expected to decline by 0.25%, France's CAC 40 by 0.15%, and Italy's FTSE MIB slightly below the flatline [1] - Global market sentiment is being influenced by U.S. stock futures trading near the flatline after a positive session, driven by gains in technology stocks and strength in financials and energy sectors [3] Earnings Reports - A busy day of earnings is anticipated with companies such as Nestle, Rio Tinto, and Zurich Insurance reporting their results [2] - Airbus expects to deliver 870 commercial aircraft in 2026, which is slightly below the analysts' expectation of approximately 880 [2] Oil Market - Oil prices increased by over 4% following comments from U.S. Vice President JD Vance regarding Iran's nuclear talks, indicating potential military action if diplomatic efforts fail [4] Regional Market Activity - In Asia-Pacific markets, stocks traded higher as several exchanges returned from the Lunar New Year holiday [4]

Core Viewpoint - Nestle is considering reducing its involvement in the ice cream business, including a potential reduction of its stake in the Froneri joint venture, as it reviews various options [1]. Group 1: Company Actions - Nestle is evaluating options to decrease its presence in the ice cream sector, which may involve selling some of its fully-owned ice cream operations to Froneri [1]. - The company has not provided any comments regarding these deliberations, and Froneri has not responded to inquiries [1]. Group 2: Froneri Joint Venture - Froneri, a joint venture between PAI Partners and Nestle, was recently valued at 15 billion euros (approximately $17.69 billion) following investments from Goldman Sachs and the Abu Dhabi Investment Authority [1]. - PAI Partners may consider increasing its stake in Froneri if Nestle opts to reduce its shareholding, or Nestle could sell part of its stake to other investors like ADIA [1]. Group 3: Market Context - Froneri produces well-known ice cream brands such as Haagen-Dazs and Rowntree's, and it competes with the newly independent Magnum Ice Cream Company, which separated from Unilever last year [1].

Core Viewpoint - Nestle and Danone are under scrutiny due to significant infant formula recalls, with investors demanding clarity on the financial implications and the companies' responses to the crisis [1] Group 1: Company Responses and Financial Impact - Nestle initiated recalls in December across Europe, Asia, and the Americas due to potential contamination with cereulide, a toxin causing nausea and vomiting [1] - Danone has not commented on the situation, while Nestle is focused on replenishing stocks [1] - Analysts expect Nestle's financial exposure from the recalls to be around €1.6 billion ($1.9 billion), despite the company estimating that less than 0.5% of group sales are affected [1] Group 2: Market Reactions and Reputation Risks - The recalls have negatively impacted both companies' stock performance, with Danone's shares down over 5% this year, while Nestle's shares have shown some recovery [1] - Experts indicate that restoring reputation is critical in the infant formula market, as trust has been compromised among consumers [1] - Competitors like HiPP have seen increased demand due to the recalls, while Nestle's NAN formula has been affected despite being a bright spot in their portfolio [1] Group 3: Regulatory and Competitive Landscape - French authorities have launched investigations into how the recalls were managed, raising concerns about the speed of the response [1] - Danone is particularly vulnerable, with approximately 17% of its total profits derived from infant formula sales in China, where contamination risks are a significant concern for parents [1] - The recalls may lead to a reduction in Nestle's volume-growth forecast by around 100 basis points, as analysts question the company's ability to manage such crises effectively [1]

Core Viewpoint - A crisis has emerged over contaminated baby formula, leading to multiple product recalls and investigations into major dairy companies, causing concern among parents and investors [1] Group 1: Investigation and Legal Actions - The Paris public prosecutor has opened investigations into five companies, including Nestle, Danone, and Lactalis, regarding potentially contaminated infant nutrition products [1] - The investigation is based on allegations of "deception regarding goods posing a danger to human health," which could result in penalties of up to seven years in prison and fines up to €3.75 million ($4.45 million) [3] Group 2: Health Concerns - Recalls were initiated due to possible contamination with cereulide, a toxin that can cause nausea, vomiting, and diarrhea, with symptoms typically resolving within a day but potentially leading to severe complications [2] - The French health ministry is investigating three reported baby deaths linked to the consumption of the recalled infant formula, although no causal link has been established yet [5] Group 3: Company Responses - Nestle's CEO expressed regret over the distress caused to parents and customers, emphasizing that safety and well-being are the company's highest priorities [4]

经济观察网据国家市场监督管理总局网站2月12日晚消息，针对近期雀巢婴配乳粉因检出蜡样芽胞杆菌呕吐毒素预防性召回事件，国务院食安 办、市场监管总局高度重视，已督促雀巢(中国)有限公司完成其在中国大陆销售的特定批次产品召回工作。 截至目前，我国未发现因食用婴幼儿配方乳粉导致蜡样芽胞杆菌呕吐毒素中毒的确诊病例。 市场监管总局已部署各地强化婴幼儿配方乳粉质量安全管控，督促所有生产企业开展蜡样芽胞杆菌呕吐毒素检测，严格原料验收和产品出厂把 关，全力保障婴幼儿配方乳粉质量安全。 ...

Recent Events - On January 6, 2026, Nestlé announced a precautionary recall of certain infant formula products in 31 countries due to potential contamination with Bacillus cereus from a supplier's arachidonic acid oil. This recall affects 30 batches of products in the Chinese market, including brands like "力多精" and "铂初能恩." The potential impact on brand trust and supplier relationships warrants ongoing attention [2]. Strategic Initiatives - In October 2025, Nestlé announced plans to lay off approximately 16,000 employees globally (6% of total workforce) over the next two years, focusing on optimizing white-collar and marketing positions. The goal is to achieve annual cost savings of 1 billion Swiss francs by 2027. The Chinese market is included in this restructuring framework. Starting January 1, 2026, Nestlé will merge its infant nutrition business with Wyeth Nutrition to form the "Nestlé Nutrition Business," led by谢国耀. Additionally, the CEO of the China region, 马凯思, is driving a shift from a "channel-driven" to a "demand-driven" approach, integrating e-commerce teams to enhance efficiency [3]. Performance Overview - For the first three quarters of 2025, Nestlé's organic growth rate in the Greater China region was -6.1%, with the third quarter dropping to -10.4%. The pricing contribution rate remained negative at -3.2%, indicating that price reductions did not effectively boost sales. Global sales amounted to 65.9 billion Swiss francs, reflecting a year-on-year decline of 1.9% [4]. Stock Performance - On January 6, 2026, Nestlé's U.S. stock trading volume surged by 88.91%, with the stock price declining by 1.22% to $95.55. Over the past 60 days, the cumulative increase was 3.21%, but there was a cumulative decline of 3.27% from the beginning of the year to January 6 [5]. Industry Environment - The competitive landscape in the Chinese market is intensifying, with domestic brands such as 飞鹤 and 君乐宝 increasing their market share in the infant formula sector. Brands like 瑞幸 and Manner are also diverting coffee consumption demand. Additionally, historical food safety issues, such as the 2023 recall incident in Canada, combined with the recent recall, may prolong the brand trust recovery period [6].